2026 Annual Meeting | C42 - Case Studies: Challenges in Stroke Treatment and Prevention

Date Saturday 04/18/26

Time 05:30 PM - 07:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry B. Goldstein, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Using case examples, presenters will engage participants in a discussion and review of contrioversial topics in stroke prevention and acute treatment.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Event Timeline
05:30 PM - 05:35 PM CDT	Speaker	Course Overview Larry B. Goldstein, MD, FAHA, FAAN
05:35 PM - 06:05 PM CDT	Speaker	Controversies in the Use of Antithrombotics and Thrombolytics in the Setting of Treatment with Anti-amyloid Beta Immunotherapy Larry B. Goldstein, MD, FAHA, FAAN
06:05 PM - 06:20 PM CDT	Speaker	Controversies in the Management of Asymptomatic Extracranial Carotid Artery Stenosis Seemant Chaturvedi, MD, FAHA, FAAN
06:20 PM - 06:35 PM CDT	Speaker	Controversies in the Management of Symptomatic Extracranial Carotid Artery Stenosis Seemant Chaturvedi, MD, FAHA, FAAN
06:35 PM - 06:50 PM CDT	Speaker	Controversies in Stroke Prevention in the Setting of Elevated Lipoprotein(a) Nada El Husseini, MD, FAAN
06:50 PM - 07:05 PM CDT	Speaker	Controversies in the Management of Radiation Vasculopathy Nada El Husseini, MD, FAAN
07:05 PM - 07:30 PM CDT	Q&A	Questions and Answers Larry B. Goldstein, MD, FAHA, FAAN, Seemant Chaturvedi, MD, FAHA, FAAN, Nada El Husseini, MD, FAAN

Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Nada El Husseini, MD, FAAN	Dr. El Husseini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH. The institution of Dr. El Husseini has received research support from American Heart Association. The institution of Dr. El Husseini has received research support from PCORI.

��ɫ��

��ɫ��